Astal Laboratories Limited (BSE: 512600)
Health Care · Pharmaceuticals · IN
Rs81.70
-5.21% today · -0.7% 1Y
Astal Laboratories Limited (BSE: 512600) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $37.30M.
Over the last twelve months the share price has lost 0.7%, trading between 60.45 and 103.20.
Tweenvest scores Astal Laboratories Limited across four factors: quality 23/100, value 58/100. Its strongest factor is value.
512600 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $37.30M
- Revenue (TTM)
- $34.07M
- P/E
- 15.54
- EPS
- 5.26
- Dividend yield
- —
- Beta (5Y)
- -0.45
- 52-week high
- Rs103.20
- 52-week low
- Rs60.45
- Avg volume (3M)
- —
- Shares outstanding
- 43.69M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,243.27 | -0.29% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.91 | -0.78% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.84 | +0.12% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.70 | +0.08% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £122.08 | +0.81% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.89 | -0.29% |
Figures last refreshed Aug 18, 2026.